[EN] SUBSTITUTED PYRIMIDINE COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSITIONS DE PYRIMIDINES A SUBSTITUTION ET MODES D'UTILISATION
申请人:ELAN PHARM INC
公开号:WO2000027824A1
公开(公告)日:2000-05-18
Substituted pyrimidines that have general structure (I) in which the symbol R1 represents a C¿1?-C6 alkyl, C1-C6 alkoxy or halogen atom; R?2¿ represents a phenyl group, substituted phenyl group, benzyl moiety, substituted benzyl moiety, C¿3?-C7 cycloalkyl, or substituted C3-C7 cycloalkyl; R?3¿ represents a hydrogen or C¿1?-C6 alkyl group; R?4¿ represents -H, -OH, -N¿3? or -NHCOCH3; and R?5¿ represents H are provided. These compounds have activity as inhibitors of phospholipase A¿2?, and are useful in treating disorders mediated by phospholipase A2.